CoChat

SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

A new technology, SUGAR-seq, enables simultaneous detection of surface glycans, epitopes, transcripts, and TCR repertoire.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.abe3610

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Development and implementation of SUGAR-seq. (A) Schematic representation of SUGAR-seq. TILs (CD3+ TCR+) were isolated from day 14 B16-Ova and MC38-Ova tumors (n = 6, pooled) by FACS. TILs were initially stained with biotinylated (1 μg/ml) and nonbiotinylated L-Pha (1:5 ratio), washed extensively, and then stained with ADT antibodies (anti–PD-1, anti-TIM3, and anti-biotin) and hash-tagging antibodies for sample demultiplexing. Single-cell capture was performed using the 10x Genomics platform. (B) UMAP clustering of TILs derived from combined B16-Ova and MC38-Ova tumors based on RNA markers from SUGAR-seq. NK, natural killer. (C) UMAP clustering displaying the L-Pha signal (ADT) from SUGAR-seq, on TILs derived from B16-Ova and MC38-Ova tumors combined. (D) UMAP clustering from SUGAR-seq displaying the ADT signal for PD-1, TIM3, and RNA expression of particular cluster markers from SUGAR-seq. (E) Violin plot of the L-Pha signal (ADT) across the clusters identified in (B). (F) TILs were determined to be L-Phalow or L-Phahigh via separation around a detection (ADT L-Pha) z score of 0, followed by CD8+ cluster frequency analysis. (G) The L-Pha signal (ADT) is displayed surrounding the z score on CD8+ B16-Ova TILs.
Fig. 1 Development and implementation of SUGAR-seq. (A) Schematic representation of SUGAR-seq. TILs (CD3+ TCR+) were isolated from day 14 B16-Ova and MC38-Ova tumors (n = 6, pooled) by FACS. TILs were initially stained with biotinylated (1 μg/ml) and nonbiotinylated L-Pha (1:5 ratio), washed extensively, and then stained with ADT antibodies (anti–PD-1, anti-TIM3, and anti-biotin) and hash-tagging antibodies for sample demultiplexing. Single-cell capture was performed using the 10x Genomics platform. (B) UMAP clustering of TILs derived from combined B16-Ova and MC38-Ova tumors based on RNA markers from SUGAR-seq. NK, natural killer. (C) UMAP clustering displaying the L-Pha signal (ADT) from SUGAR-seq, on TILs derived from B16-Ova and MC38-Ova tumors combined. (D) UMAP clustering from SUGAR-seq displaying the ADT signal for PD-1, TIM3, and RNA expression of particular cluster markers from SUGAR-seq. (E) Violin plot of the L-Pha signal (ADT) across the clusters identified in (B). (F) TILs were determined to be L-Phalow or L-Phahigh via separation around a detection (ADT L-Pha) z score of 0, followed by CD8+ cluster frequency analysis. (G) The L-Pha signal (ADT) is displayed surrounding the z score on CD8+ B16-Ova TILs.CC BY-NC · PubMed Central
Fig. 2 Validation of SUGAR-seq. (A) TILs from day 14 B16-Ova tumors were FACS gated as CD8+ TCR+ CD3+, followed by selecting CD44+ CD62L+/− and then analyzed for N-glycan abundance through detection of FITC-conjugated L-Pha. (B) L-Phahigh and L-Phalow CD8+ TILs from (A) (right-hand panel) were analyzed for expression of PD-1 and TIM3 by FACS. Bar charts represent the frequency of PD-1 TIM3–positive or PD-1 TIM3–negative CD8+ TILs across L-Phalow or L-Phahigh subsets. Data points represent individual mice. *P < 0.01. (C) TILs (CD45+ CD8+) from day 14 B16-Ova tumors were FACS analyzed for the indicated surface proteins, L-Pha staining, and intracellular proteins as indicated. TSNE clustering is depicted. Bar charts represent the mean fluorescence intensity (MFI) of the indicated TFs in CD45+ CD8+ TILs across L-Phalow or L-Phahigh subsets. Data points represent individual mice. *P < 0.01.
Fig. 2 Validation of SUGAR-seq. (A) TILs from day 14 B16-Ova tumors were FACS gated as CD8+ TCR+ CD3+, followed by selecting CD44+ CD62L+/− and then analyzed for N-glycan abundance through detection of FITC-conjugated L-Pha. (B) L-Phahigh and L-Phalow CD8+ TILs from (A) (right-hand panel) were analyzed for expression of PD-1 and TIM3 by FACS. Bar charts represent the frequency of PD-1 TIM3–positive or PD-1 TIM3–negative CD8+ TILs across L-Phalow or L-Phahigh subsets. Data points represent individual mice. *P < 0.01. (C) TILs (CD45+ CD8+) from day 14 B16-Ova tumors were FACS analyzed for the indicated surface proteins, L-Pha staining, and intracellular proteins as indicated. TSNE clustering is depicted. Bar charts represent the mean fluorescence intensity (MFI) of the indicated TFs in CD45+ CD8+ TILs across L-Phalow or L-Phahigh subsets. Data points represent individual mice. *P < 0.01.CC BY-NC · PubMed Central
Fig. 3 SUGAR-seq analysis of lymph node–derived T cells. (A) Schematic representation of SUGAR-seq experimental design. T cells (CD3+ TCR+) were isolated from the lymph node (LN) of a healthy C57BL/6 mouse, the lymph node of a C57BL/6 mouse carrying a day 14 B16 subcutaneous tumor (diseased lymph node), or the TILs from that mouse by FACS. Cells were initially stained with biotinylated (1 μg/ml) and nonbiotinylated L-Pha (1:5 ratio), washed extensively, then stained with anti-biotin ADT and hash-tagging antibodies for sample demultiplexing. Single-cell capture was performed using the 10x Genomics platform. (B) UMAP clustering of populations derived from combined samples described in (A) based on RNA markers. (C) Violin plots of CD4 and CD8a transcript levels across the UMAP clusters described in (B). (D) UMAP plots displaying the expression of the indicated genes across diseased lymph node, healthy lymph node, and TIL conditions. (E) UMAP plots displaying the ADT–L-Pha signal genes across diseased lymph node, healthy lymph node, and TIL conditions. (F) Violin plot of ADT–L-Pha signal across the UMAP clusters described in (B).
Fig. 3 SUGAR-seq analysis of lymph node–derived T cells. (A) Schematic representation of SUGAR-seq experimental design. T cells (CD3+ TCR+) were isolated from the lymph node (LN) of a healthy C57BL/6 mouse, the lymph node of a C57BL/6 mouse carrying a day 14 B16 subcutaneous tumor (diseased lymph node), or the TILs from that mouse by FACS. Cells were initially stained with biotinylated (1 μg/ml) and nonbiotinylated L-Pha (1:5 ratio), washed extensively, then stained with anti-biotin ADT and hash-tagging antibodies for sample demultiplexing. Single-cell capture was performed using the 10x Genomics platform. (B) UMAP clustering of populations derived from combined samples described in (A) based on RNA markers. (C) Violin plots of CD4 and CD8a transcript levels across the UMAP clusters described in (B). (D) UMAP plots displaying the expression of the indicated genes across diseased lymph node, healthy lymph node, and TIL conditions. (E) UMAP plots displaying the ADT–L-Pha signal genes across diseased lymph node, healthy lymph node, and TIL conditions. (F) Violin plot of ADT–L-Pha signal across the UMAP clusters described in (B).CC BY-NC · PubMed Central
Fig. 4 SUGAR-seq identifies TILs with divergent epigenetic and functional capacities. (A) Schematic representation of ex vivo RNA-seq and ATAC-seq. TILs (CD3+ TCR+ CD8+ CD44+) were FACS sorted on L-Phalow and L-Phahigh from day 14 B16-Ova tumors (three pools of six mice), followed by 3′ bulk RNA-seq and ATAC-seq analysis. (B) Chromatin accessibility heatmap for L-Phalow and L-Phahigh TILs from (A). Chromatin accessibility peaks for the granzyme cluster locus and the S1pr1 locus are displayed on the right. (C) RNA-seq heatmap for significantly differentially regulated genes comparing L-Phalow and L-Phahigh TILs from (A). (D) Heatmap of overlapping significantly differentially regulated genes from ATAC-seq and RNA-seq comparing L-Phalow and L-Phahigh TILs from (A). (E) Venn diagram analysis of overlapping significantly differentially regulated genes from ATAC-seq and RNA-seq comparing L-Phalow and L-Phahigh TILs from (A). (F) GSEA analysis of the RNA-seq analysis from (A). (G) Overlapping significantly differentially regulated genes from the bulk RNA-seq (A) and pseudobulk analysis significantly differentially regulated genes from SUGAR-seq data (Fig. 1). (H) Correlation between aggregated single-cell sequencing (pseudobulk) and ex vivo bulk RNA-seq. FC, fold change.
Fig. 4 SUGAR-seq identifies TILs with divergent epigenetic and functional capacities. (A) Schematic representation of ex vivo RNA-seq and ATAC-seq. TILs (CD3+ TCR+ CD8+ CD44+) were FACS sorted on L-Phalow and L-Phahigh from day 14 B16-Ova tumors (three pools of six mice), followed by 3′ bulk RNA-seq and ATAC-seq analysis. (B) Chromatin accessibility heatmap for L-Phalow and L-Phahigh TILs from (A). Chromatin accessibility peaks for the granzyme cluster locus and the S1pr1 locus are displayed on the right. (C) RNA-seq heatmap for significantly differentially regulated genes comparing L-Phalow and L-Phahigh TILs from (A). (D) Heatmap of overlapping significantly differentially regulated genes from ATAC-seq and RNA-seq comparing L-Phalow and L-Phahigh TILs from (A). (E) Venn diagram analysis of overlapping significantly differentially regulated genes from ATAC-seq and RNA-seq comparing L-Phalow and L-Phahigh TILs from (A). (F) GSEA analysis of the RNA-seq analysis from (A). (G) Overlapping significantly differentially regulated genes from the bulk RNA-seq (A) and pseudobulk analysis significantly differentially regulated genes from SUGAR-seq data (Fig. 1). (H) Correlation between aggregated single-cell sequencing (pseudobulk) and ex vivo bulk RNA-seq. FC, fold change.CC BY-NC · PubMed Central
Fig. 5 Integration of SUGAR-seq and TCR-seq reveals that tumor reactivity alters the N-glycosylation state of T cells. (A) Monocle was used to calculate pseudotime analysis of CD8+ TIL clusters from pooled B16-Ova and MC38-Ova tumors from SUGAR-seq. (B) L-Phalow and L-Phahigh gene signatures were generated from the bulk RNA-seq (A) and visualized on SUGAR-seq CD8+ T cell clusters using AUCell. The L-Pha ADT signal is visualized in the right-hand panel. (C) Boxplots of AUCell analysis of memory and effector gene signatures (GOLDRATH_EFF_VS_MEMORY_CD8_TCELL) and bulk RNA-seq–derived L-Pha signatures (B) across CD8+ T cell clusters. (D) Monocle pseudotime analysis of ADTs L-Pha, PD-1, and TIM3 on CD8+ TIL clusters from pooled B16-Ova and MC38-Ova tumors (SUGAR-seq). (E) TCR-seq clonotypes for L-Phalow and L-Phahigh CD8+ TILs (separated around an ADT L-Pha z score of 0) from pooled B16-Ova and MC38-Ova tumors. Right-hand panel: Clonotype frequency of CD8+ TILs from L-Phalow and L-Phahigh subpopulations, derived from B16-Ova tumors. (F) UMAP of CD4 transcript–expressing clusters from B16-Ova TILs. (G) TCR-seq clonotypes across CD4+ UMAP clusters described in (F). (H) Violin plot of the ADT–L-Pha signal across Cd4+ UMAP clusters, split by “clonal” (Top6 + Clone7–36 + Clone37–150) and “rare” (rare + NA).
Fig. 5 Integration of SUGAR-seq and TCR-seq reveals that tumor reactivity alters the N-glycosylation state of T cells. (A) Monocle was used to calculate pseudotime analysis of CD8+ TIL clusters from pooled B16-Ova and MC38-Ova tumors from SUGAR-seq. (B) L-Phalow and L-Phahigh gene signatures were generated from the bulk RNA-seq (A) and visualized on SUGAR-seq CD8+ T cell clusters using AUCell. The L-Pha ADT signal is visualized in the right-hand panel. (C) Boxplots of AUCell analysis of memory and effector gene signatures (GOLDRATH_EFF_VS_MEMORY_CD8_TCELL) and bulk RNA-seq–derived L-Pha signatures (B) across CD8+ T cell clusters. (D) Monocle pseudotime analysis of ADTs L-Pha, PD-1, and TIM3 on CD8+ TIL clusters from pooled B16-Ova and MC38-Ova tumors (SUGAR-seq). (E) TCR-seq clonotypes for L-Phalow and L-Phahigh CD8+ TILs (separated around an ADT L-Pha z score of 0) from pooled B16-Ova and MC38-Ova tumors. Right-hand panel: Clonotype frequency of CD8+ TILs from L-Phalow and L-Phahigh subpopulations, derived from B16-Ova tumors. (F) UMAP of CD4 transcript–expressing clusters from B16-Ova TILs. (G) TCR-seq clonotypes across CD4+ UMAP clusters described in (F). (H) Violin plot of the ADT–L-Pha signal across Cd4+ UMAP clusters, split by “clonal” (Top6 + Clone7–36 + Clone37–150) and “rare” (rare + NA).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 87

Metadata

Authors
Kearney, C. J., Vervoort, S. J., Ramsbottom, K. M., Todorovski, I., Lelliott, E. J., Zethoven, M., Pijpers, L., Martin, B. P., Semple, T., Martelotto, L., Trapani, J. A., Parish, I. A., Scott, N. E., Oliaro, J., & Johnstone, R. W.
Affiliations
  • The University of Melbourne (AU)
  • Peter MacCallum Cancer Centre (AU)
Corresponding author
  • Kearney, Conor J.
  • Oliaro, Jane
  • Johnstone, Ricky W.
Venue
Science Advances
Published
2021-02-19
Volume
7
Issue
8
ISSN
2375-2548 (ISSN-L)
OpenAlex
W3132655657
Cited by
87
References
37
Citations by year
2026: 16 · 2025: 10 · 2024: 21 · 2023: 11 · 2022: 25 · 2021: 4
FWCI
4.79
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
Funders
  • National Health and Medical Research Council
  • Cancer Council Victoria
  • National Breast Cancer Foundation
  • The Kid’s Cancer Project
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
Keywords
N-glycosylation, extracellular epitope, single-cell transcriptomics, tumor-infiltrating T cells, glycoproteome, post-translational modification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells. https://app.cochat.ai/papers/10.1126/sciadv.abe3610
The paper
Kearney, C. J., Vervoort, S. J., Ramsbottom, K. M., Todorovski, I., Lelliott, E. J., Zethoven, M., Pijpers, L., Martin, B. P., Semple, T., Martelotto, L., Trapani, J. A., Parish, I. A., Scott, N. E., Oliaro, J., & Johnstone, R. W. (2021). SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells. Science Advances. https://doi.org/10.1126/sciadv.abe3610

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.